For staged bilateral knee arthroplasty patients, 100% clinical pathway adherence including perineural catheters and multimodal analgesia is feasible despite multiple variables. We believe that patient-centered acute pain management requires consistent and reliable delivery of care.
Objectives
To determine the incidence and 1-year outcomes of an elderly population with perioperative atrial arrhythmia (PAA) within 7 days of hip fracture surgery.
Design
Retrospective cohort study.
Setting
The Rochester Epidemiology Project (REP).
Participants
Elderly adults consecutive undergoing hip fracture repair from 1988 to 2002 in Olmsted County, Minnesota (N=1,088, mean age 84.0 ± 7.4, 80.2% female).
Measurements
Baseline clinical variables were analyzed in relation to survival using Cox proportional hazards methods for comparison.
Results
Sixty-one participants (5.6%) developed PAA within the first 7 days. During 1 year of follow-up, 239 (22%) participants died. PAA was associated with greater mortality (45% vs 21%; hazard ratio (HR)=2.8, 95% confidence interval (CI)=1.9–4.2). Other mortality risk factors were male sex (HR=2.0, 95% CI=1.5–2.6), congestive heart failure (HR=2.1, 95% CI=1.7–2.8), chronic renal insufficiency (HR=2.0, 95% CI=1.5–2.8), dementia (HR=2.9, 95% CI=2.2–3.7), and American Society of Anesthesiologists risk Class III, IV, or V (HR=3.3, 95% CI=1.9–5.9).
Conclusion
Elderly adults undergoing hip fracture surgery who develop PAA within 7 days have significantly higher 1-year mortality than those who do not. Further studies are indicated to determine whether prevention of PAA will reduce mortality in this population.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.